Medico-economic Interest of Single-use Ancillary Efficiency® in Fitting a GMK® Total Knee Arthroplasty (TKA) (IMEDUU)
Primary Purpose
Knee Arthropathy
Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
knee total arthroplasty with two types of ancillaries
Sponsored by
About this trial
This is an interventional other trial for Knee Arthropathy
Eligibility Criteria
Inclusion Criteria:
- Patient with gonarthrosis or inflammatory arthrosis of the knee leading to surgical indication for total knee arthroplasty
- Informed patient, able to understand the information, not opposing to participate this protocol
- patient affiliate to social security
Exclusion Criteria:
- Extra-joint Deformation needing bone associated gesture
- Preoperative active or suspected infection
- Local evolutive tumoral pathology
- Medical history with bone gesture on concerned knee
- Patient unable or refusing to give his consentement
- Pregnant woman or in age to be pregnant without use any effective contraceptive method
- Patient under maintenance of justice, tutelage or legal guardianship)
- Presence of any family, sociological, political or geographic situation able to interfere with the protocol
Sites / Locations
- CHU de Nantes (University Hospital of Nantes)
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Arm A: metallic reusable ancillary.
Arm B: Efficiency single use ancillary.
Arm Description
This control group will be constituted of patients who will have the GMK® prosthesis with metallic reusable ancillary.
This group will be constituted of patients who will have the GMK® prosthesis with Efficiency single use ancillary.
Outcomes
Primary Outcome Measures
Mean production cost of the surgical intervention (total knee arthroplasty) each arm, from an hospital perspective, using a micro-costing approach with items reported in a eCRF
Mean production cost of the surgical intervention in each arm is calculated thanks to 2 steps : 1) Quantification of health resources consumed during the surgical intervention (transport, cleaning, reconditionning sterilization of ancillaries, time spent by medical staff, nurses and materials used. (These data will be collected on a paper sheet and reported in a eCRF for 20 patients (10 per group)) ; 2) Valuation of health resources consumed with hospital cost accounting, mean wages, and purchase prices of materials.
Secondary Outcome Measures
Incremental cost-utility ratio comparing single use ancillary versus reusable ancillary
Incremental cost-utility ratio comparing single use versus reused ancillaries
clinical functional result in each group (Total KSS score)
Total KSS score
clinical functional result in each arm
Total KSS score
HKA angle
HKA angle will be measured using a whole-leg radiograph (X-rays)
HKA angle
HKA angle will be measured using a whole-leg radiograph (X-rays)
Number of Adverse events in each arm
All complications related to the material or occurring in the postoperative year will be reported and compared (anemia, phlebitis, hematoma, scar disunity, scar necrosis, nosocomial infection, fracture)
Euroqol EQ-5D-5L quality-of-life questionnaire (5 questions with 5 possible answers)
Answers to EQ-5D-5L are used to calculate QALYs which represent a measure of survival weighted by health-related quality-of-life factors so that a weight of 0 represents death and a weight of 1 represents the best imaginable health status.
Euroqol EQ-5D-5L quality-of-life questionnaire (5 questions with 5 possible answers)
Answers to EQ-5D-5L are used to calculate QALYs which represent a measure of survival weighted by health-related quality-of-life factors so that a weight of 0 represents death and a weight of 1 represents the best imaginable health status.
qualitative score of surgeon's perception about ancillary (1-Excellent, 2-Good, 3- Difficult, 4- Unsure)
This qualitative score will be measured during the intervention and will include 4 levels evaluating grip and comfort
Excellent (good position in a few seconds, no doubt)
Good (easy to use for the first time)
Difficult (several attempts, difficult handling, uncomfortable)
Unsure (persistence of doubt during use)
weight of waste
contaminated and uncontaminated waste will be weighed at the exit of the operating room
Full Information
NCT ID
NCT04300439
First Posted
January 16, 2020
Last Updated
March 6, 2020
Sponsor
Nantes University Hospital
Collaborators
Medacta USA
1. Study Identification
Unique Protocol Identification Number
NCT04300439
Brief Title
Medico-economic Interest of Single-use Ancillary Efficiency® in Fitting a GMK® Total Knee Arthroplasty (TKA)
Acronym
IMEDUU
Official Title
Medico-economic Interest of Single-use Ancillary Efficiency® in Fitting a GMK® Total Knee Arthroplasty (TKA)
Study Type
Interventional
2. Study Status
Record Verification Date
March 2020
Overall Recruitment Status
Unknown status
Study Start Date
March 2020 (Anticipated)
Primary Completion Date
March 2023 (Anticipated)
Study Completion Date
March 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Nantes University Hospital
Collaborators
Medacta USA
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Clinical studies on single-use ancillaries are still few; medico-economic benefits have to be assessed regarding their design and use.
A foreseeable increase in the number of surgeries in the future, tends to change the techniques and consequently to question the medico-economic context. Single-use ancillaries attempt to provide solutions to today's imperatives and could be relevant from a global medico-economic point of view.
For the moment, the conventional ancillaries for TKA are reused after sterilization.
The objective of the study is to improve the fluidity of the intervention process with cost control.
Detailed Description
After validation of the inclusion criteria, the surgeon will perform the randomization (1:1): single-use ancillary group or conventional ancillary group. Only the medical team and the block staff will be informed about the ancillary group, not the patient.
The use of the single-use ancillary does not induce any modification of the surgical technique for fitting a TKA. The surgical approach is unchanged and is specific to the surgeon. The appearance and use of the single-use ancillary are similar to the conventional ancillary except for the materials used for their design. Please note that a preliminary training at the beginning of the study will be carried out with the different investigators so that they can handle the different medical devices.
In total, 48 participants will be randomized. The medico-economics assessments will be performed for 20 patients (10 per group) by micro-costing to evaluate the preoperative, intraoperative and post-operative costs : reconditioning time, sterilization and transport time, preparation time and duration of intervention. The qualitative score of subjective assessment of the operator's perception of the ancillary measured during the intervention. The participants will evaluate their QOL by completing a questionnaire 3 month and 12 month postoperative. The safety parameters will also be collected.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Knee Arthropathy
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
48 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Arm A: metallic reusable ancillary.
Arm Type
Active Comparator
Arm Description
This control group will be constituted of patients who will have the GMK® prosthesis with metallic reusable ancillary.
Arm Title
Arm B: Efficiency single use ancillary.
Arm Type
Experimental
Arm Description
This group will be constituted of patients who will have the GMK® prosthesis with Efficiency single use ancillary.
Intervention Type
Device
Intervention Name(s)
knee total arthroplasty with two types of ancillaries
Intervention Description
-For the Arm A, the surgical procedure of knee total arthroplasty will be done with metallic reusable ancillary.
For the Arm B, the surgical procedure of knee total arthroplasty will be done with Efficiency single use ancillary.
Primary Outcome Measure Information:
Title
Mean production cost of the surgical intervention (total knee arthroplasty) each arm, from an hospital perspective, using a micro-costing approach with items reported in a eCRF
Description
Mean production cost of the surgical intervention in each arm is calculated thanks to 2 steps : 1) Quantification of health resources consumed during the surgical intervention (transport, cleaning, reconditionning sterilization of ancillaries, time spent by medical staff, nurses and materials used. (These data will be collected on a paper sheet and reported in a eCRF for 20 patients (10 per group)) ; 2) Valuation of health resources consumed with hospital cost accounting, mean wages, and purchase prices of materials.
Time Frame
Day 0
Secondary Outcome Measure Information:
Title
Incremental cost-utility ratio comparing single use ancillary versus reusable ancillary
Description
Incremental cost-utility ratio comparing single use versus reused ancillaries
Time Frame
1 year
Title
clinical functional result in each group (Total KSS score)
Description
Total KSS score
Time Frame
1 year postoperative
Title
clinical functional result in each arm
Description
Total KSS score
Time Frame
3 months postoperative
Title
HKA angle
Description
HKA angle will be measured using a whole-leg radiograph (X-rays)
Time Frame
1 year postoperative
Title
HKA angle
Description
HKA angle will be measured using a whole-leg radiograph (X-rays)
Time Frame
3 months postoperative
Title
Number of Adverse events in each arm
Description
All complications related to the material or occurring in the postoperative year will be reported and compared (anemia, phlebitis, hematoma, scar disunity, scar necrosis, nosocomial infection, fracture)
Time Frame
1 year postoperative
Title
Euroqol EQ-5D-5L quality-of-life questionnaire (5 questions with 5 possible answers)
Description
Answers to EQ-5D-5L are used to calculate QALYs which represent a measure of survival weighted by health-related quality-of-life factors so that a weight of 0 represents death and a weight of 1 represents the best imaginable health status.
Time Frame
1 year postoperative
Title
Euroqol EQ-5D-5L quality-of-life questionnaire (5 questions with 5 possible answers)
Description
Answers to EQ-5D-5L are used to calculate QALYs which represent a measure of survival weighted by health-related quality-of-life factors so that a weight of 0 represents death and a weight of 1 represents the best imaginable health status.
Time Frame
3 months postoperative
Title
qualitative score of surgeon's perception about ancillary (1-Excellent, 2-Good, 3- Difficult, 4- Unsure)
Description
This qualitative score will be measured during the intervention and will include 4 levels evaluating grip and comfort
Excellent (good position in a few seconds, no doubt)
Good (easy to use for the first time)
Difficult (several attempts, difficult handling, uncomfortable)
Unsure (persistence of doubt during use)
Time Frame
Day 0
Title
weight of waste
Description
contaminated and uncontaminated waste will be weighed at the exit of the operating room
Time Frame
Day 0
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient with gonarthrosis or inflammatory arthrosis of the knee leading to surgical indication for total knee arthroplasty
Informed patient, able to understand the information, not opposing to participate this protocol
patient affiliate to social security
Exclusion Criteria:
Extra-joint Deformation needing bone associated gesture
Preoperative active or suspected infection
Local evolutive tumoral pathology
Medical history with bone gesture on concerned knee
Patient unable or refusing to give his consentement
Pregnant woman or in age to be pregnant without use any effective contraceptive method
Patient under maintenance of justice, tutelage or legal guardianship)
Presence of any family, sociological, political or geographic situation able to interfere with the protocol
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mike Persigant, MD
Phone
02 40 08 37 78
Email
mike.persigant@chu-nanets.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Ingrid Bénard
Phone
0253482879
Email
ingrid.benard@chu-nantes.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mike Persigant, MD
Organizational Affiliation
Nantes University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU de Nantes (University Hospital of Nantes)
City
Nantes
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mike Persigant, MD
Email
mike.persigant@chu-nantes.fr
First Name & Middle Initial & Last Name & Degree
Mike Persigant, MD
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Medico-economic Interest of Single-use Ancillary Efficiency® in Fitting a GMK® Total Knee Arthroplasty (TKA)
We'll reach out to this number within 24 hrs